Back to BAKER BROS. ADVISORS LP

BCYC
Showing 8 of 15 quarters

Position history for BAKER BROS. ADVISORS LP's holdings in BICYCLE THERAPEUTICS PLC

BAKER BROS. ADVISORS LP holds 10.9M shares of BCYC (BICYCLE THERAPEUTICS PLC), worth $50.5M as of 2026-Q1. BCYC represents 0.3% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$50.5M

Current Shares

10.9M

Total Value Change

-$139.7M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
10.9M
0.0%
$50.5M0.3%$5.50
0
2025-Q4
Unchanged
10.9M
0.0%
$77.1M0.5%$6.80
0
2025-Q3
Unchanged
10.9M
0.0%
$84.3M0.6%$7.61
0
2025-Q2
Unchanged
10.9M
0.0%
$75.7M0.7%$7.24
0
2025-Q1
Unchanged
10.9M
0.0%
$92.4M1.0%$8.97
0
2024-Q4
Increased
10.9M
+15.8%
$152.4M1.6%$14.13
55
2024-Q3
Unchanged
9.4M
0.0%
$212.7M2.2%$23.21
0
2024-Q2
Increased
9.4M
+90.2%
$190.3M2.4%$20.24
82

Other major holders of BCYC: Janus Henderson Group Ltd., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used